MedTrace Logo

Treatment Response Prediction System of mCRC Patients Based on CTC

NCT04917276 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-06-08

No results posted yet for this study

Summary

This study enrolling patients with metastatic colorectal cancer. Detecting CTC at different points in the treatment process. Descripting the molecular atlas of CTC in mCRC patients. Building and validating a response prediction system of mCTC patients.

Conditions

  • Colorectal Cancer Stage IV
  • Circulating Tumor Cell

Interventions

DIAGNOSTIC_TEST

Circulating tumor cell

Detecting CTC in different time points of treatment (like PR, PD, pre and post-operation)

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-15
Primary Completion
2023-12-01
Completion
2025-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04917276 on ClinicalTrials.gov